Silverfin false false 30/09/2024 01/10/2023 30/09/2024 Dr Simon Graeme Mylrea Edwards 11/09/2019 Suzanne Elizabeth Edwards 11/09/2019 14 April 2025 The principal activity of the Company during the financial period was the provision of specialist medical consultancy services. 12201024 2024-09-30 12201024 bus:Director1 2024-09-30 12201024 bus:Director2 2024-09-30 12201024 2023-09-30 12201024 core:CurrentFinancialInstruments 2024-09-30 12201024 core:CurrentFinancialInstruments 2023-09-30 12201024 core:ShareCapital 2024-09-30 12201024 core:ShareCapital 2023-09-30 12201024 core:RetainedEarningsAccumulatedLosses 2024-09-30 12201024 core:RetainedEarningsAccumulatedLosses 2023-09-30 12201024 core:OfficeEquipment 2023-09-30 12201024 core:OfficeEquipment 2024-09-30 12201024 bus:OrdinaryShareClass1 2024-09-30 12201024 2023-10-01 2024-09-30 12201024 bus:FilletedAccounts 2023-10-01 2024-09-30 12201024 bus:SmallEntities 2023-10-01 2024-09-30 12201024 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 12201024 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 12201024 bus:Director1 2023-10-01 2024-09-30 12201024 bus:Director2 2023-10-01 2024-09-30 12201024 core:OfficeEquipment core:TopRangeValue 2023-10-01 2024-09-30 12201024 2022-10-01 2023-09-30 12201024 core:OfficeEquipment 2023-10-01 2024-09-30 12201024 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 12201024 bus:OrdinaryShareClass1 2022-10-01 2023-09-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12201024 (England and Wales)

SW NEUROLOGY CONSULTATION LTD

Unaudited Financial Statements
For the financial year ended 30 September 2024
Pages for filing with the registrar

SW NEUROLOGY CONSULTATION LTD

Unaudited Financial Statements

For the financial year ended 30 September 2024

Contents

SW NEUROLOGY CONSULTATION LTD

STATEMENT OF FINANCIAL POSITION

As at 30 September 2024
SW NEUROLOGY CONSULTATION LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 September 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 0 12
0 12
Current assets
Debtors 4 5,294 3,610
Cash at bank and in hand 41,160 27,408
46,454 31,018
Creditors: amounts falling due within one year 5 ( 5,872) ( 5,365)
Net current assets 40,582 25,653
Total assets less current liabilities 40,582 25,665
Net assets 40,582 25,665
Capital and reserves
Called-up share capital 6 100 100
Profit and loss account 40,482 25,565
Total shareholders' funds 40,582 25,665

For the financial year ending 30 September 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of SW Neurology Consultation Ltd (registered number: 12201024) were approved and authorised for issue by the Board of Directors on 14 April 2025. They were signed on its behalf by:

Dr Simon Graeme Mylrea Edwards
Director
SW NEUROLOGY CONSULTATION LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
SW NEUROLOGY CONSULTATION LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

SW Neurology Consultation Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is The Old Post Office, Holbeton, Plymouth, PL8 1NE, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Office equipment 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Office equipment Total
£ £
Cost
At 01 October 2023 300 300
At 30 September 2024 300 300
Accumulated depreciation
At 01 October 2023 288 288
Charge for the financial year 12 12
At 30 September 2024 300 300
Net book value
At 30 September 2024 0 0
At 30 September 2023 12 12

4. Debtors

2024 2023
£ £
Amounts owed by directors 1,780 0
Prepayments and accrued income 3,514 3,610
5,294 3,610

5. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to directors 0 404
Accruals 2,370 2,039
Taxation and social security 3,502 2,922
5,872 5,365

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100

7. Related party transactions

Transactions with the entity's directors

2024 2023
£ £
Amounts owed by (to) directors 1,780 (404)

Advances were made to the directors during the year totalling £2,184. The loan is interest-free and has no fixed date for repayment. The amount outstanding at the year-end was £1,780.